Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis. Achten RE, Van Luijk C, Van der Rijst L, Bakker D, et al. Acta Derm Venereol 2022 Jan 31. doi: 10.2340/actadv.v101.1128.

Read + Share

Amedeo Smart

Independent Medical Education

Achten RE, Van Luijk C, Van der Rijst L, Bakker D, et al. Identification of Risk Factors for Dupilumab-associated Ocular Surface Disease in Patients with Atopic Dermatitis. Acta Derm Venereol 2022 Jan 31. doi: 10.2340/actadv.v101.1128.
PMID: 35098318